Nationwide Xanax recall raises concerns over the anxiety drug’s quality control A safety recall has been issued for one specific batch of Xanax due to a quality issue. The FDA announced that the drugmaker Viatris is pulling a single lot of the extended-release (XR) 3-milligram tablets because they may not dissolve properly in the body. This could affect how the medication is absorbed and how well it works. The risk to patients is considered very low and temporary. The recall is labeled as “Class II,” meaning any health problems from the defect would be minor and reversible. No adverse reactions…

Newswire

Features

The Latest